<DOC>
	<DOCNO>NCT01499043</DOCNO>
	<brief_summary>The main objective study evaluate effect body PLX3397 male subject CRPC . Secondary objective include evaluate safety tolerability PLX3397 antitumor effect PLX3397 subject .</brief_summary>
	<brief_title>Pilot Study PLX3397 Patients With Advanced Castration-Resistant Prostate Cancer ( CRPC )</brief_title>
	<detailed_description />
	<mesh_term>Prostatic Neoplasms</mesh_term>
	<criteria>Histologically confirm prostate cancer , currently objective progressive disease . Castrate level testosterone ( &lt; 50 ng/dL ) . Baseline circulate tumor cell ( CTC ) count â‰¥10/7.5 mL blood . Archival tumor tissue ( unstained section , paraffin block , frozen tumor tissue ) requisition shipment central laboratory . Karnofsky performance status 80100 . Adequate organ marrow function . The subject receive : Any systemic chemotherapy ( include investigational agent ) within 4 week ( exception nitrosoureas/mitomycin C within 6 week ) , first dose study treatment , OR Biological agent ( antibody , immune modulators , cytokine , vaccine ) within 6 week first dose study treatment , OR Hormonal anticancer therapy ( include LHRH agonist antagonist ) within 2 week first dose study treatment . Specific restriction prior hormonal anticancer treatment detailed inclusion criterion , OR Smallmolecular kinase inhibitor type investigational agent within 4 week first dose study treatment 5 halflives compound active metabolite , whichever short . The subject receive drug use control loss bone mass ( e.g. , bisphosphonates ) within 4 week prior first dose study treatment . The subject symptomatic uncontrolled brain metastasis epidural disease require current treatment include steroid anticonvulsant . The subject correct QT interval calculate Fridericia formula ( QTcF ) &gt; 450 m screening . The subject uncontrolled significant intercurrent illness include , limited , following condition : Cardiovascular disorder symptomatic congestive heart failure ( CHF ) , *Uncontrolled hypertension Unstable angina pectoris , clinicallysignificant cardiac arrhythmia History stroke ( include transient ischemic attack [ TIA ] ischemic event ) within 6 month study treatment Myocardial infarction within 6 month study treatment History thromboembolic event require therapeutic anticoagulation within 6 month study treatment main portal vein vena cava thrombosis occlusion .</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2015</verification_date>
	<keyword>CRPC</keyword>
	<keyword>Prostate Cancer</keyword>
	<keyword>Bone metastasis</keyword>
	<keyword>Advanced Castration-Resistant Prostate Cancer ( CRPC )</keyword>
</DOC>